STUDY OF THE EFFICACY AND SAFETY OF ONCE IN A MONTH 100 MG SINGLE DOSE OF MIFEPRISTONE (RU-486)AS A CONTRACEPTIVE AGENT. - MOM 100

Trial Profile

STUDY OF THE EFFICACY AND SAFETY OF ONCE IN A MONTH 100 MG SINGLE DOSE OF MIFEPRISTONE (RU-486)AS A CONTRACEPTIVE AGENT. - MOM 100

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2018

At a glance

  • Drugs Mifepristone (Primary) ; Ethinylestradiol/levonorgestrel; Ferrous fumarate
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top